RxDoctor Payments Data

Jeanne Habash, PA

Physician Assistant · Great Bend, KSNPI 1376593947

Payments from drug & device makers

$567in general payments, 2019–2025

Across 32 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$88
  • AstraZeneca$68
  • GSK$64
  • Abbott$64
  • AbbVie$63
  • Novo Nordisk$55
  • plus $166 from 11 others

What the payments were for

  • Food & beverage$567100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$567 in reported general payments places this provider in the 60th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas

Medicare billing

Part B allowed, 2024
$6,908
Medicare patients
157
Services billed
679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide52$60,084
FarxigaDapagliflozin Propanediol46$38,092
MounjaroTirzepatide29$27,454
MyrbetriqMirabegron38$26,903
JanuviaSitagliptin Phosphate18$21,927
JardianceEmpagliflozin13$20,483
EliquisApixaban21$18,965
RybelsusSemaglutide13$14,877
TrulicityDulaglutide15$14,367
UbrelvyUbrogepant13$13,168
XareltoRivaroxaban16$9,047
AbrysvoRsv Vacc, Pref A And Pref B/Pf24$7,731
ShingrixVaricella-Zoster Ge/As01b/Pf26$5,928
Varenicline Tartrate37$5,285
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$4,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$55$74,96165 claims
AstraZenecaFarxiga, Symbicort$68$41,67758 claims
PfizerEliquis, Abrysvo$23$26,69645 claims
MerckJanuvia$14$21,92718 claims
Boehringer IngelheimJardiance$18$20,48313 claims
AbbVieUbrelvy$63$13,16813 claims
GSKShingrix$64$5,92826 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,016 physician assistant providers in Kansas.

Other physician assistant in Great Bend

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →